Quest Diagnostics Incorporated (DGX)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 9,872,000 | 9,539,000 | 9,346,000 | 9,287,000 | 9,252,000 | 9,297,000 | 9,488,000 | 9,603,000 | 9,883,000 | 10,294,000 | 10,582,000 | 10,679,000 | 10,788,000 | 11,046,000 | 11,058,000 | 10,335,000 | 9,437,000 | 8,361,000 | 7,531,000 | 7,657,000 |
| Total current assets | US$ in thousands | 2,392,000 | 2,623,000 | 2,017,000 | 2,228,000 | 2,372,000 | 1,815,000 | 1,733,000 | 1,814,000 | 1,898,000 | 2,334,000 | 2,426,000 | 2,475,000 | 2,741,000 | 2,854,000 | 2,146,000 | 2,999,000 | 3,058,000 | 3,348,000 | 2,380,000 | 1,560,000 |
| Total current liabilities | US$ in thousands | 2,169,000 | 2,092,000 | 2,012,000 | 2,298,000 | 1,815,000 | 1,618,000 | 1,875,000 | 1,355,000 | 1,551,000 | 1,602,000 | 1,577,000 | 1,700,000 | 1,753,000 | 1,759,000 | 1,551,000 | 1,707,000 | 1,776,000 | 2,389,000 | 1,843,000 | 1,129,000 |
| Working capital turnover | 44.27 | 17.96 | 1,869.20 | — | 16.61 | 47.19 | — | 20.92 | 28.48 | 14.06 | 12.46 | 13.78 | 10.92 | 10.09 | 18.58 | 8.00 | 7.36 | 8.72 | 14.02 | 17.77 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $9,872,000K ÷ ($2,392,000K – $2,169,000K)
= 44.27
Quest Diagnostics Incorporated's working capital turnover has shown significant fluctuation over the periods provided. The company's working capital turnover ratio ranged from a high of 47.19 to a low of 1,869.20 which indicates a wide variance in how efficiently the company is utilizing its working capital to generate revenue.
In general, a high working capital turnover indicates that Quest Diagnostics is efficient in generating sales using its working capital. However, extremely high or low values may be indicative of anomalies or errors in the financial data provided, such as in the case of the very high ratio of 1,869.20 in June 30, 2024.
It is important for investors and analysts to further investigate the reasons behind such extreme values to ensure the accuracy and reliability of the financial information. Additionally, monitoring the trend of the working capital turnover ratio over time can provide insights into the company's operational efficiency and financial health.
Peer comparison
Dec 31, 2024